Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2012
04/17/2012CA2372181C Adjuvant combination formulations
04/17/2012CA2371625C Polyamines and their use in therapy
04/17/2012CA2202090C Papilloma virus-like particles, fusion proteins as well as processes for their production
04/12/2012WO2012048235A1 Vitamin e formulations of sulfamide ns3 inhibitors
04/12/2012WO2012048202A2 Method of preparation of antiviral compounds and useful intermediates thereof
04/12/2012WO2012048119A2 Anti-biofilm compositions and methods for using
04/12/2012WO2012048013A2 Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections
04/12/2012WO2012047907A1 Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
04/12/2012WO2012047893A2 Use of rifazil and analogues thereof to treat ocular disorders
04/12/2012WO2012047870A2 Antimicrobial preservation of propofol emulsions
04/12/2012WO2012047852A2 Compositions and methods for modulating immunodeficiency virus transcription
04/12/2012WO2012047764A1 Therapeutic antiviral peptides
04/12/2012WO2012047732A2 Antibody compositions and methods of use
04/12/2012WO2012047487A1 2-pyridone antimicrobial compositions
04/12/2012WO2012047207A1 Compositions for treating chronic viral infections
04/12/2012WO2012047133A1 Anti-viral agent against influenza b
04/12/2012WO2012047132A1 Interferon-inducing agent for the treatment of acute viral respiratory infections
04/12/2012WO2012047131A1 Anti-viral agent against influenza b
04/12/2012WO2012047130A1 Interferon-inducing agent for the treatment of acute viral respiratory infections
04/12/2012WO2012046653A1 Amine compound and use for same
04/12/2012WO2012046078A1 Novel composition
04/12/2012WO2012046062A1 Use of prodrugs to avoid gi mediated adverse events
04/12/2012WO2012045894A1 Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus
04/12/2012WO2012045883A1 Cyclopropylamine inhibitors of oxidases
04/12/2012WO2012045803A1 Co-crystals and salts of ccr3-inhibitors
04/12/2012WO2012045801A1 Lactoferrin based complex coacervates and their uses
04/12/2012WO2012045704A1 New treatments of hepatitis c virus infection
04/12/2012WO2012045285A1 Pharmaceutical composition and application thereof
04/12/2012WO2012045280A1 Salts and polymorphs of sulfamide ns3 inhibitors
04/12/2012WO2012045237A1 Hsp90 inhibitor, preparation method and use thereof
04/12/2012WO2012045210A1 Pharmaceutical composition for treating septic shock and its use
04/12/2012WO2012045198A1 Use of polysaccharides from radix isatidis in manufacture of medicaments against influenza virus
04/12/2012WO2012045157A1 Arih2 regulates dendritic cell activation and autoimmunity
04/12/2012WO2012045150A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
04/12/2012WO2012045124A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls
04/12/2012WO2012021514A3 System and method for reverting antibiotic tolerance of bacterial persister cells
04/12/2012WO2012017327A3 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
04/12/2012WO2012017323A3 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
04/12/2012WO2012006104A3 Compounds and methods for treating tuberculosis infection
04/12/2012WO2012003361A3 Nanoemulsion vaccines
04/12/2012WO2011163321A3 Composition and method of treating lipid encapsulated virus infections
04/12/2012WO2011160020A3 Carbapenem antibacterials with gram-negative activity
04/12/2012WO2011159471A3 Linked purine pterin hppk inhibitors useful as antibacterial agents
04/12/2012WO2011158039A8 Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (rsv) infection
04/12/2012WO2011146621A9 Treatment of clostridium difficile infection in patients undergoing antibiotic therapy
04/12/2012WO2011139709A9 Methods of treating retroviral infections and related dosage regimes
04/12/2012WO2011130650A3 Antibodies for the treatment of clostridium difficile-associated infection and disease
04/12/2012WO2011100477A3 Antibodies and processes for preparing the same
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120089110 Absorbent Article with Lotion
04/12/2012US20120088827 Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088814 Methods of modulating an immune response to a viral infection
04/12/2012US20120088813 Anti viral therapy
04/12/2012US20120088804 Clevidipine emulsion formulations containing antimicrobial agents
04/12/2012US20120088781 Famciclovir for the Treatment of Recurrent genital Herpes Labialis with a one day application
04/12/2012US20120088774 Active pharmaceutical ingredient adsorbed on solid support
04/12/2012US20120088762 Compounds for enzyme inhibition
04/12/2012US20120088756 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
04/12/2012US20120088750 Antibacterial compounds
04/12/2012US20120088740 Co-crystals and pharmaceutical compositions comprising the same
04/12/2012US20120088739 Method for treating meibomian gland disease
04/12/2012US20120088726 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
04/12/2012US20120088718 Hcv-derived polypeptides and uses thereof
04/12/2012US20120088717 Method for treating fungal infection with antifungal bifunctional molecules
04/12/2012US20120088715 Mutated antithrombins, a process for preparing the same and their use as drugs
04/12/2012US20120088671 Anti-biofilm compositions and methods for using
04/12/2012US20120088664 Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur subtituent
04/12/2012US20120088663 Triazole Compounds Carrying a Sulfur Substituent
04/12/2012US20120088660 Antifungal 1,2,4-triazolyl Derivatives
04/12/2012US20120088297 Mycobacterial antigens expressed under low oxygen tension
04/12/2012US20120088270 Methods for producing antifungal bifunctional molecules for treating fungal infection
04/12/2012US20120088264 Methods for determining efficacy of chemotherapeutic agents
04/12/2012US20120087994 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox
04/12/2012US20120087989 Use of gelled prp (platelet gel) for volumetric breast reconstruction
04/12/2012US20120087984 Stabilization of chemical compounds using nanoparticulate formulations
04/12/2012US20120087976 Adjuvant compositions comprising a non-ionic isotonicity agent
04/12/2012US20120087974 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
04/12/2012US20120087973 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES
04/12/2012US20120087972 Winnie wipes
04/12/2012US20120087966 Antimicrobial foam
04/12/2012US20120087947 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
04/12/2012US20120087945 Method for keeping an immunogenic composition available for administration to an animal
04/12/2012US20120087944 Oral vaccine fast-dissolving dosage form using starch
04/12/2012US20120087939 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
04/12/2012US20120087938 Consensus/ancestral immunogens
04/12/2012US20120087937 Novel compositions
04/12/2012US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies
04/12/2012US20120087930 Marker of Streptococcus Anginosus/ Streptococcus Constellatus (MOAC) and Uses Thereof
04/12/2012US20120087924 Recombinant B. pseudomallei Adhesin Protein and Methods and Uses Thereof
04/12/2012US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
04/12/2012US20120087904 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
04/12/2012US20120087900 Immunotherapeutic agent
04/12/2012US20120087893 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
04/12/2012US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances
04/12/2012US20120087876 Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea
04/12/2012US20120087858 Dual variable domain immunoglobulins and uses thereof
04/12/2012CA2813993A1 Method of preparation of antiviral compounds and useful intermediates thereof
04/12/2012CA2813734A1 Use of rifalazil and analogues thereof to treat ocular disorders
04/12/2012CA2813337A1 Salts and polymorphs of sulfamide ns3 inhibitors
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 1798